Tumor-associated macrophages, angiogenesis, and tumor cell migration in oral squamous cell carcinoma
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To investigate the relationship between tumor-associated macrophages (TAMs), neovascularization, and tumor cell migration in oral squamous cell carcinoma (OSCC) of an African subpopulation. MATERIALS AND METHODS: Twenty OSCC paraffin blocks underwent immunohistochemistry to TAM1 (CCR7), TAM2 (CD206), Twist, E-cadherin, N-cadherin, and CD34. The relative percentage of CCR7 + and CD206 + cells to overall immune cell population was calculated for three high power fields and an average was taken. TAM-related microvessel density (MVD) was determined as the mean of the three recorded values. Cases that had no CD34 + vessels adjacent to the TAMs region were regarded as having an MVD score of 0. RESULTS: Ten cases (50%) expressed greater CCR7 activity than CD206, seven cases (35%) expressed approximately equal activity of CCR7 and CD206, while three cases (15%) expressed greater activity of CD206 than CCR7. Twist expression was strong in some cases with strong N-cadherin and weak E-cadherin, but the expression of Twist was not consistently high in all cases that expressed strong N-cadherin and weak E-cadherin. CONCLUSIONS: TAMs distribution suggested antitumor activity and the potential for tumor metastasis was only partly due to Twist-mediated epithelial-mesenchymal transition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089 · cited 1×
“[1] The progression of tumors is characterized by the recruitment of innate and adaptive immune cells through cytokines and chemokines to the tumor site, and macrophages are especially abundant during tumor evolution.[2] Macrophages are hematopoietic cells in the innate immune system, which phagocytose cellular debris…”
BackgroundDistinct role of macrophages in different tumor microenvironments
Lewis, C. E., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4005 · Cited by 2,225 · cited 2×
“This describes a tumor microenvironment that is mostly antitumor, unlike the submission by Lewis and Pollard,[3] where the microenvironment is a co-conspirator to promote tumor progression.”
BackgroundBissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180 · cited 1×
“The tumor microenvironment has such a great impact on the status of the tumor cells that it has been reported that a normal microenvironment can prevent malignant cells from committing to neoplasia and even reverse the malignant phenotype though the cancer cells retain their mutations.[1] The progression of tumors is…”
BackgroundBingle, L., Brown, N. J., & Lewis, C. E. (2002) · The Journal of Pathology · doi:10.1002/path.1027 · Cited by 2,022 · cited 1×
“The role of TAMs is controversial because there is evidence for their participation in protumor as well as antitumor activities.[4] TAMs release several potent pro-angiogenic cytokines and growth factors such as vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-8.”
BackgroundWheelock, M. J., Shintani, Y., Maeda, M., Fukumoto, Y., & Johnson, K. R. (2008) · Journal of Cell Science · doi:10.1242/jcs.000455 · Cited by 767 · cited 2×
“[10] However, abnormal expression of cadherins, or cadherin switching, is a key event in the EMT of some cancers, including OSCC.”
BackgroundCytokine regulation of angiogenesis in breast cancer: the role of tumor-associated macrophages
Lewis, C. E., Leek, R., Harris, A., & McGee, J. O. (1995) · Journal of Leukocyte Biology · doi:10.1002/jlb.57.5.747 · Cited by 286 · cited 2×
“They also express some angiogenesis-modulating enzymes including matrix metalloproteinase-2 (MMP-2) and MMP-9.”
BackgroundTumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.021 · Cited by 243
Monocytes and Macrophages in Cancer: Development and Functions
Richards, D. M., Hettinger, J., & Feuerer, M. (2013) · Cancer Microenvironment · doi:10.1007/s12307-012-0123-x · Cited by 210
Koide, N., Nishio, A., Sato, T., Sugiyama, A., & Miyagawa, S.-I. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.30733.x · Cited by 158 · cited 1×
“It is also reported that TAMs appear to play roles in the release of metastatic cells from the primary tumor as well as the establishment of secondary tumors at distant sites.[6] TAMs actually exist in two distinctive states: one is the classically activated (M1) state and the other is the otherwise activated (M2) sta…”
BackgroundN-cadherin as a therapeutic target in cancer
Mariotti, A., Perotti, A., Sessa, C., & Rüegg, C. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.4.451 · Cited by 122 · cited 3×
“Although most cases could be said to have good prognosis in this study based on the microenvironment biology, the neoplastic cells displayed relatively strong N-cadherin expression, which promotes metastasis and angiogenesis and is associated with poor survival.[9] Consequently, we can conclude that the patients’ outl…”
BackgroundResultInfluential
Cited by
Tumor microenvironment complexity and therapeutic implications at a glance
Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-0530-4 · Cited by 1,784
“For one, TAM strengthens angiogenesis by production of VEGF-A, TNFα, urokinase plasminogen activator (uPA), FGF, adrenomedullin (ADM), and semaphorin 4D (Sema4D) thymidine phosphorylase (TP), lymphangigensis (secretion of VEGF-A, VEGF-C, VEGF-D, CXCL8, MMP2, MMP9) fueling cancer invasion and metastasis [96, 98, 99] .”
BackgroundEpithelial‐to‐mesenchymal transition in oral squamous cell carcinoma: Challenges and opportunities
Ling, Z., Cheng, B., & Tao, X. (2021) · International Journal of Cancer · doi:10.1002/ijc.33352 · Cited by 222
Dan, H., Liu, S., Liu, J., Liu, D., Yin, F., Wei, Z., Wang, J., Zhou, Y., Jiang, L., Ji, N., et al. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12644 · Cited by 218
“In addition, Udeabor et al. (2017) found that there were more M1 macrophages than M2 macrophages in most OSCC tissues, but the M2 number was higher than the M1 number in only 15% of the tissues.”
BackgroundCarbosilane dendrimers: Drug and gene delivery applications
Rabiee, N., Ahmadvand, S., Ahmadi, S., Fatahi, Y., Dinarvand, R., Bagherzadeh, M., Rabiee, M., Tahriri, M., Tayebi, L., & Hamblin, M. R. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101879 · Cited by 96
“These macrophages play an important role in the processes of angiogenesis and tumor metastasis, and are considered to be target prevent tumor progression [[78], [79], [80], [81]].”
BackgroundShao, S., Miao, H., & Ma, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1295684 · Cited by 70
Platelet-rich fibrin secretome induces three dimensional angiogenic activation in vitro
Herrera-Vizcaíno, C., Dohle, E., Al‐Maawi, S., Booms, P., Sader, R., Kirkpatrick, C. J., Choukroun, J., & Ghanaati, S. (2019) · European Cells and Materials · doi:10.22203/ecm.v037a15 · Cited by 44
Self-citationMutant P53 in the formation and progression of the tumor microenvironment: Friend or foe
Asl, E. R., Rostamzadeh, D., Duijf, P. H. G., Mafi, S., Mansoori, B., Barati, S., Cho, W. C. S., & Mansoori, B. (2023) · Life Sciences · doi:10.1016/j.lfs.2022.121361 · Cited by 40
Sun, M., Qiu, S., Xiao, Q., Wang, T., Tian, X., Chen, C., Wang, X., Han, J., Zheng, H., Shou, Y., et al. (2020) · Medical Oncology · doi:10.1007/s12032-020-01426-1 · Cited by 27
“Immunohistochemical analysis of oral squamous cell carcinoma samples indicated that in most cases, M1 macrophages outnumber M2 macrophages in the TME, suggesting that TAMs are involved in precancerous lesions and also have antitumor activity [31].”
BackgroundHan, G., Lu, K., Xu, W., Zhang, S., Huang, J., Dai, C., Sun, G., & Ye, J. (2019) · Oncology Letters · doi:10.3892/ol.2019.10317 · Cited by 20
Wu, R.-S., Lin, J., Xing, Y.-M., Gao, W.-L., Jiang, Y., Chen, L.-X., Zhang, X., & Dai, Z. (2021) · Immunology Letters · doi:10.1016/j.imlet.2021.05.004 · Cited by 13
Targeted therapy for head and neck squamous cell carcinoma microenvironment
Guo, Z., Li, K., Liu, P., Zhang, X., Lv, J., Zeng, X., & Zhang, P. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1257898 · Cited by 15
“In addition, TAMs also play a role in regulating the adhesion, migration, and invasion of HNSCC cells, promote metastasis by supporting the generation of blood vessels and lymphatic vessels, and contribute to tumor progression via immunosuppression (86).”
BackgroundRenu, K., Vinayagam, S., Veeraraghavan, V. P., Mukherjee, A. G., Wanjari, U. R., Prabakaran, D. S., Ganesan, R., Dey, A., Vellingiri, B., Kandasamy, S., et al. (2022) · Vaccines · doi:10.3390/vaccines10091490 · Cited by 6
“; the accumulation of tumor-associated macrophages can cause tumor metastasis due to EMT activation [31] (Table 1).”
BackgroundCARD9 downregulation suppresses the growth of oral squamous cell carcinoma by regulating NF‐κB
Ye, L., Zhou, X., Yin, X., Shang, Y., Xiao, Y., Jiang, Y., & Wen, X. (2019) · Oral Diseases · doi:10.1111/odi.13157 · Cited by 6
Mutonga, D. M. (2019) · Series of Endocrinology Diabetes and Metabolism · doi:10.54178/jsedmv1i2004 · Cited by 6
Biological implications of the immune factors in the tumour microenvironment of oral cancer
Shetty, S. S., Padam, K. S. R., Hunter, K. D., Kudva, A., & Radhakrishnan, R. A. (2021) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2021.105294 · Cited by 6
Recent Developments in the Study of the Microenvironment of Cancer and Drug Delivery
Chaudhary, B., Kumar, P., Arya, P., Singla, D., Kumar, V., Kumar, D., Roshan, S., Wadhwa, S., Gulati, M., Singh, S. K., et al. (2022) · Current Drug Metabolism · doi:10.2174/1389200224666230110145513 · Cited by 5
Singh, N. K., Awasthi, P., Gupta, A., Anand, N., Giri, B. S., Hassan, M. I., & Hasan, S. (2025) · Discover Applied Sciences · doi:10.1007/s42452-024-06260-y · Cited by 2
Teixeira, L. R. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-08052019-150524 · Cited by 1
Alves, M., Ferreira, S. Q., Garcês, F., Espíndula, C., Salazar, F., Pacheco, J. J., Freitas, M. D., Lopes, C., Warnakulasuriya, S., Delgado, L., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27156889
“Unlike macrophages in healthy tissues, tumor-associated macrophages (TAMs) may exhibit deviant functions such as phagocytosis and antigen presentation, thereby promoting tumor progression [17].”
Metadata
- Authors
- Ghanaati, S., Udeabor, S., Adisa, A., Orlowska, A., & Sader, R.
- Affiliations
- Goethe University Frankfurt (DE)
- Corresponding author
- Ghanaati, Shahram
- ORCID
- Ghanaati, Shahram
- Venue
- Annals of African Medicine
- Published
- 2017
- Volume
- 16
- Issue
- 4
- Pages
- 181
- ISSN
- 0975-5764 (ISSN-L)
- 1596-3519
- PMC
- PMC5676408
- OpenAlex
- W2767128223
- Cited by
- 19
- References
- 13
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 5 · 2019: 5
- FWCI
- 1.24
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- cc-by-nc-sa
- Locations
- Annals of African Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Publication Server of Goethe University Frankfurt am Main (Goethe University Frankfurt) (submittedVersion, cc-by-nc-sa)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor-associated macrophages, oral squamous cell carcinoma, angiogenesis, tumor cell migration, CCR7, CD206, Twist, epithelial-mesenchymal transition, N-cadherin, E-cadherin, microvessel density, metastasis
- MeSH terms
- Adult, Carcinoma, Squamous Cell, Cell Movement, Female, Humans, Immunohistochemistry, Macrophages, Male, Mouth Neoplasms, Neovascularization, Pathologic, Biomarkers, Tumor, Antigens, CD, Cadherins, Twist-Related Protein 1, Epithelial-Mesenchymal Transition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.